Charlie's Holdings Q2 Revenue Jumps 116% to $3.8M, FDA Signals Non-Enforcement on 30 PACHA SKUs
CHUC sits 47% above its 52-week low of $0.15.
Summary
Charlie's Holdings reported Q2 2026 revenue of $3.8 million, up 116% year-over-year, with gross profit up 130% to $1.1 million and gross margin improving to 29.4%. Operating loss widened 29% to $1.2 million, and cash fell to $0.5 million from $1.3 million at year-end. The company also disclosed that the FDA tentatively identified 30 PACHA SKUs for inclusion on its non-enforcement priority webpage, a favorable regulatory signal. Insiders purchased 1.35 million restricted shares at $0.20 per share in the first half of 2026, and management plans to test-market America's first age-gated flavored disposables. This follows the Q1 2026 10-Q showing 204% revenue growth and recent capital raises, indicating continued momentum but ongoing cash burn.
At the time of this announcement, CHUC was trading at $0.22 on OTC in the Trade & Services sector, with a market capitalization of approximately $62M. The 52-week trading range was $0.15 to $0.38. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.